Preliminary experiments show conolidine may well inhibit specific ion channels, decreasing neuronal excitability and limiting suffering alerts. This system is especially applicable in neuropathic discomfort, where by irregular signaling leads to persistent pain. On top of that, conolidine seems to affect G protein-coupled receptor (GPCR) pathways integral to pain https://henrye283zrh9.blog2freedom.com/profile